KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Neogenomics (NEO) Receivables - Other (2017 - 2024)

Neogenomics' Receivables - Other history spans 8 years, with the latest figure at $100000.0 for Q4 2024.

  • For Q4 2024, Receivables - Other rose 170.27% year-over-year to $100000.0; the TTM value through Dec 2024 reached $100000.0, up 170.27%, while the annual FY2024 figure was $100000.0, 170.27% up from the prior year.
  • Receivables - Other reached $100000.0 in Q4 2024 per NEO's latest filing, down from $236000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $2.7 million in Q3 2022 to a low of $37000.0 in Q4 2023.
  • Average Receivables - Other over 5 years is $1.4 million, with a median of $1.6 million recorded in 2020.
  • Peak YoY movement for Receivables - Other: surged 802.88% in 2020, then tumbled 98.05% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $1.6 million in 2020, then rose by 5.78% to $1.7 million in 2021, then grew by 9.21% to $1.9 million in 2022, then crashed by 98.05% to $37000.0 in 2023, then soared by 170.27% to $100000.0 in 2024.
  • Per Business Quant, the three most recent readings for NEO's Receivables - Other are $100000.0 (Q4 2024), $236000.0 (Q1 2024), and $37000.0 (Q4 2023).